qpatch assay software v5.0 (Sophion Bioscience)
90
Structured Review
Sophion Bioscience
qpatch assay software v5.0
Qpatch Assay Software V5.0, supplied by Sophion Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qpatch+assay+software+v5%2E0/qpatch+assay+software/pm38901106-354-9-13
Average 90 stars, based on 1 article reviews
Qpatch Assay Software V5.0, supplied by Sophion Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qpatch+assay+software+v5%2E0/qpatch+assay+software/pm38901106-354-9-13
Average 90 stars, based on 1 article reviews
qpatch assay software v5.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi Article Snippet: Electrophysiology data for Na v channels were assessed using the Software:Article Title: Hybrid molecules combining GABA-A and serotonin 5-HT 6 receptors activity designed to tackle neuroinflammation associated with depression. Article Snippet: There is clear evidence that the presence of inflammatory factors and impaired GABA-ergic neurotransmission in depressed patients is associated with poor clinical outcome.. We designed hybrid molecules, bearing the GABA molecule assembled with chemical fragments that interact with the serotonin 5-HT6 receptor.. Such a combination aimed to curb neuroinflammation, remodel GABA-ergic signaling, and provide antidepressant-like activity. Article Title: Dual 5-HT 6 /SERT ligands for mitigating neuropsychiatric symptoms of dementia exerting neuroprotection against amyloid-β toxicity, memory preservation, and antidepressant-like properties. Article Snippet: In light of the biological targets alterations in dementia patients suffering from neuropsychiatric symptoms, particularly in the 5-HT6 receptor and SERT transporters, this study aimed to develop dual-acting molecules targeting both these targets.. By combining a 5-substituted indole with piperazine scaffolds, we synthesized molecules with nanomolar affinities for these sites, avoiding interaction with off-targets detrimental to dementia patients.. Preliminary pharmacodynamic and ADMET assays let the identification of compound 15 as a lead molecule. Article Title: 2-(4-Fluorophenyl)-1 H -benzo[ d ]imidazole as a Promising Template for the Development of Metabolically Robust, α1β2γ2GABA-A Receptor-Positive Allosteric Modulators Article Snippet: .. The data obtained were processed using Article Title: Evaluation of Some Safety Parameters of Dual Histamine H 3 and Sigma-2 Receptor Ligands with Anti-Obesity Potential. Article Snippet: .. Data were analyzed using Article Title: Dual Molecules Targeting 5-HT 6 and GABA-A Receptors as a New Approach to Combat Depression Associated with Neuroinflammation Article Snippet: .. The acquired data were examined with Article Title: Biphenyloxy-alkyl-piperidine and azepane derivatives as histamine H 3 receptor ligands. Article Snippet: Novel biphenyloxy-alkyl derivatives of piperidine and azepane were synthesized and evaluated for their binding properties at the human histamine H3 receptor.. Two series of compounds were obtained with a metaand a parabiphenyl moiety.. The alkyl chain spacer contained five and six carbon atoms. Inhibition:Article Title: Dual 5-HT 6 /SERT ligands for mitigating neuropsychiatric symptoms of dementia exerting neuroprotection against amyloid-β toxicity, memory preservation, and antidepressant-like properties. Article Snippet: In light of the biological targets alterations in dementia patients suffering from neuropsychiatric symptoms, particularly in the 5-HT6 receptor and SERT transporters, this study aimed to develop dual-acting molecules targeting both these targets.. By combining a 5-substituted indole with piperazine scaffolds, we synthesized molecules with nanomolar affinities for these sites, avoiding interaction with off-targets detrimental to dementia patients.. Preliminary pharmacodynamic and ADMET assays let the identification of compound 15 as a lead molecule. Concentration Assay:Article Title: Dual 5-HT 6 /SERT ligands for mitigating neuropsychiatric symptoms of dementia exerting neuroprotection against amyloid-β toxicity, memory preservation, and antidepressant-like properties. Article Snippet: In light of the biological targets alterations in dementia patients suffering from neuropsychiatric symptoms, particularly in the 5-HT6 receptor and SERT transporters, this study aimed to develop dual-acting molecules targeting both these targets.. By combining a 5-substituted indole with piperazine scaffolds, we synthesized molecules with nanomolar affinities for these sites, avoiding interaction with off-targets detrimental to dementia patients.. Preliminary pharmacodynamic and ADMET assays let the identification of compound 15 as a lead molecule. |